comparemela.com

Latest Breaking News On - Dr reddy amp 039s laboratories - Page 1 : comparemela.com

Dr Reddy s Q2 FY22 Results: Dr Reddy s Laboratories Net Profit Rises 30% To Rs 992 Crore In July-September Quarter

Dr Reddy's Q2 Results: The pharma major's revenue from operations in the second quarter of the current fiscal stood at Rs 5,763 crore, compared to Rs 4,896 crore in the same quarter last year

Stocks To Watch In Trade Today (September 6, 2021): Ashoka Buildcon, Dr Reddy s Laboratories, ICICI Lombard

Ashoka Buildcon has received the letter of award from Adani Road Transport for the execution of civil and associated works of the national corridor NH-19 from Pangarh to Palsit in West Bengal

Sputnik V Vaccine India - Your Questions About Newest COVID-19 Shot Answered

Sputnik V COVID-19 vaccines were developed by Russia s Gamaleya Research Institute. New Delhi: The first doses of Russia s Sputnik V COVID-19 vaccine were administered in India on Friday in a soft launch that is expected to be scaled up in the coming days. The vaccine will cost Rs 995.40 including tax for a shot, the company said, as well as announcing a single-dose variant Sputnik Light that could be approved in the next few weeks. Deepak Sapra, the CEO of APIs and Services at Dr Reddy s Laboratories, which is manufacturing the vaccines in India, spoke to NDTV in an exclusive interview, answering a host of questions from viewers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.